Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon

Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon

US Patent 10329338 · Granted Jun 25, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunostimulatory combinations2018
Methods and compositions for enhancing immune response2017
Immunotherapy comprising TLR9 ligand and CD40 ligand2015
Immunostimulatory regimen comprising administering type 1 interferon and agonist2015
Immunostimulatory regimen comprising administering type 1 interferon and agonist2015
Immunostimulatory regimen comprising administering type 1 interferon and agonist2015
Delivery of immune response modifier compounds2015
Immunostimulatory regimen comprising administering type 1 interferon and agonist2013
Immunostimulatory regimen comprising administering type 1 interferon and agonist2013
Immunostimulatory regimen comprising administering type 1 interferon and agonist2013
Ex vivo uses of immunostimulatory combinations2012
Immunostimulatory regimen comprising administering type 1 interferon and agonist2012